News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
Content Sharing
<IPO>'Four Dragons of Domestic GPU' Enflame Completes IPO Guidance, Expected to Apply for STAR Mkt IPO
Shanghai AI chip leader, Enflame, also known as one of the "Four Dragons of Domestic GPU", completed its IPO guidance work, marking the beginning of the next stage of its...
Reset
Send
The window will close in 5 seconds
<IPO>'Four Dragons of Domestic GPU' Enflame Completes IPO Guidance, Expected to Apply for STAR Mkt IPO
Close
Recommend
26
Positive
42
Negative
16
 
 

Shanghai AI chip leader, Enflame, also known as one of the "Four Dragons of Domestic GPU", completed its IPO guidance work, marking the beginning of the next stage of its listing process, the China Securities Regulatory Commission disclosed.

TENCENT (00700.HK)  -7.400 (-1.490%)    Short selling $1.08B; Ratio 47.391%   is the largest shareholder of Enflame, having participated in multiple rounds of financing for Enflame, Chinese media reported, citing the enterprise credit inquiry platform Qichacha.

Related News M Stanley Selects 26 Chinese 'Best Business Models' Stocks (Table)
Zhao Lidong and Zhang Yalin are tied as the second-largest shareholders of Enflame. The China Integrated Circuit Industry Investment Fund (ICF) II is the fifth-largest shareholder, whereas MEITU (01357.HK)  -0.090 (-2.041%)    Short selling $48.49M; Ratio 120.924%   is the fourteenth-largest shareholder.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-04-02 16:25.)

AASTOCKS Financial News

Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.